Jose Luis Mauriz Gutiérrez-rekin lankidetzan egindako argitalpenak (1)
2024
-
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics